Featured Strategy

Mirae Asset

Concentrated exposure to Smart Beta ETFs designed to capture factor premiums across market cycles.

Learn more
CategoryThematic
No. of ETFs5 ETFs
Review CycleMonthly Review
Horizon5+ Years

Performance

How this portfolio has performed

Compare growth against a benchmark across timelines and see what a hypothetical investment would be worth today.

In the period of
Amount (₹)00.3K0.5K0.8K1K1.3KOctDecFebAprJunAugTime

Overview

Understand this portfolio

Key metrics, suitability, and strategy highlights to help you evaluate whether this model portfolio fits your goals.

Investment Objective

Smart beta factor exposure

Capture quality, momentum, and low-volatility factor premiums through a diversified ETF basket. Offers a disciplined alternative to traditional market-cap indexing over long horizons.

No. of ETFs

5 ETFs

Suggested Horizon

5+ Years

Review Cycle

Monthly

Min. Investment

₹10,000

Who this may be suitable for

Investors who understand factor investing and want rules-based exposure to quality, momentum, and low-volatility premiums through ETFs.

What investors should keep in mind

Factor strategies may lag broad markets for extended periods when a single factor falls out of favour. Diversification across factors reduces but does not eliminate this risk.

  • Multi-factor ETF basket
  • Rules-based factor tilts
  • Transparent passive implementation
  • Monthly monitoring and rebalance

Holdings

Portfolio constituents and weights

Review the ETF mix and segment allocation that defines this model portfolio.

Log in to view holdings and allocation details

FAQs

Got questions? We've got answers!

Common questions about Mirae Asset Multi-Factor and what to expect when you invest.

Mirae Asset Multi-Factor is a smart beta ETF model portfolio that combines factor exposures such as low volatility, momentum, and quality alongside core large-cap equity and a liquid debt sleeve.

Collateral

Documents and timelines

Download portfolio documents and review the scheduled rebalance checkpoints for this strategy.

Rebalance Timelines

  • Q1 Review — January 2026

    Quarterly allocation check against model targets and drift thresholds.

  • Q2 Review — April 2026

    Mid-year review of macro signals, risk metrics, and sleeve performance.

  • Q3 Review — July 2026

    Thematic and factor sleeve review with updated market regime assessment.

  • Q4 Review — October 2026

    Year-end reset to target weights and annual strategy documentation update.